세계의 체외 전사 템플릿 시장 보고서(2025년)

In-Vitro Transcription Templates Global Market Report 2025

US $ 4,490 ￦ 6,138,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,872,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,606,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

체외 전사 템플릿 시장 규모는 향후 몇 년 동안 비약적인 성장을 보일 것으로 예상되며, 2029년에는 연평균 23.4%의 CAGR로 29억 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 생명공학의 발전, 연구개발 활동에 대한 관심 증가, 체외 전사 템플릿 사용 증가, 질병의 조기 진단에 대한 수요, mRNA 기반 백신에 대한 수요 증가에 기인합니다. 예측 기간 동안 주요 동향으로는 RNA 합성 기술 개발, 기술 발전, 생명공학 기술 발전, 효소 합성 기술 발전, 자동화 및 디지털화 통합 등을 들 수 있습니다.

유전자 치료의 부상은 체외 전사 템플릿 시장의 성장을 견인할 것으로 예상됩니다. 유전자 치료는 결함이 있는 유전자를 교정하여 질병을 치료하거나 예방하기 위해 세포 유전자를 교정하는 것으로, CRISPR과 같은 기술의 발전, 막대한 투자, 최근 치료의 성공으로 이 접근법에 대한 관심이 높아지고 있습니다. 체외 전사 템플릿은 mRNA 기반 치료, siRNA 기반 치료, 유전자 편집 기술에 필요한 RNA 분자를 제공하여 유전성 질환 및 질병을 치료할 수 있게함으로써 유전자 치료에 중요한 역할을 합니다. 예를 들어, 2024년 3월 현재 미국 보건복지부 산하 연방 기관인 식품의약국(FDA)은 36개의 유전자 치료제를 승인했고, 500개의 유전자 치료제를 준비 중이라고 보고했으며, FDA는 2025년까지 매년 10-20개의 유전자 치료제를 승인할 것으로 예상하고 있습니다. 유전자 치료제에 대한 관심이 높아지면서 체외 전사 템플릿 시장의 성장을 견인할 것으로 예상하고 있습니다.

체외 전사 템플릿 시장의 주요 업체들은 RNA 기반 치료 효율과 효과를 높이고, 생산 비용을 절감하며, 다양한 치료 응용 분야에서 환자 결과를 개선하기 위해 자가 증폭 RNA 합성 서비스를 적극적으로 개척하고 있습니다. 이 기술은 숙주 세포 내에서 자가 복제가 가능한 RNA 생산을 가능하게 하여 최소한의 RNA 입력으로 고도의 단백질 발현을 가져와 RNA 기반 치료 효율과 효과를 향상시킵니다. 예를 들어, 2024년 5월 미국 생명공학 기업인 GenScript Biotech Corporation은 자가 증폭 RNA(saRNA) 합성 서비스를 발표하며 체외 전사 RNA 합성 서비스를 확대했습니다. 이 새로운 서비스는 소량의 RNA에서 강력한 단백질 발현을 가능하게함으로써 백신, 면역치료제, 유전자 치료제의 효능과 효과를 향상시키는 것을 목표로 하며, saRNA 플랫폼은 투여량을 줄이고, 생산 비용을 낮추며, 환자 결과를 개선하는 것을 목표로 하고 있습니다. 고순도 및 단백질 발현의 향상을 보장하는 광범위한 연구개발로 뒷받침되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 체외 전사 템플릿 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 체외 전사 템플릿 시장 : 성장률 분석
• 세계의 체외 전사 템플릿 시장 실적 : 규모와 성장, 2019-2024
• 세계의 체외 전사 템플릿 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 체외 전사 템플릿 전체 시장(TAM)

제6장 시장 세분화

• 세계의 체외 전사 템플릿 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 백신
• 치료적
• 세계의 체외 전사 템플릿 시장 조사 단계별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 탐색적
• 임상
• 세계의 체외 전사 템플릿 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 암
• 감염증
• 생활습관병
• 유전성 질환
• 기타 질병
• 세계의 체외 전사 템플릿 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 제약 및 바이오테크놀러지 기업
• 임상시험수탁기관(CRO)과 계약 제조 기관(CMO)
• 학술과 조사
• 기타 최종사용자
• 세계의 체외 전사 템플릿 시장, 백신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• mRNA 백신
• DNA 백신
• 세계의 체외 전사 템플릿 시장, 치료 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 유전자 치료
• RNA 기반 치료제

제7장 지역별·국가별 분석

• 세계의 체외 전사 템플릿 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 체외 전사 템플릿 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 체외 전사 템플릿 시장 : 경쟁 구도
• 체외 전사 템플릿 시장 : 기업 개요
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Genomics LLC Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Integrated DNA Technologies Inc.
• Promega Corporation
• Genescript Biotech Corporation
• Takara Bio Inc.
• New England Biolabs
• OriGene Technologies Inc.
• Cayman Chemical
• Synthego Corporation
• Synbio Technologies
• Creative Diagnostics
• VectorBuilder Inc.
• Bio-Synthesis Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 체외 전사 템플릿 시장 2029 : 새로운 기회를 제공하는 국가
• 체외 전사 템플릿 시장 2029 : 새로운 기회를 제공하는 부문
• 체외 전사 템플릿 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

In-vitro transcription templates are specific DNA sequences crafted to guide RNA synthesis under controlled laboratory conditions. These templates feature designated promoter regions recognized by RNA polymerase, enabling the efficient production of RNA molecules for diverse applications such as research, diagnostic advancements, and therapeutic development. They serve as reliable and precise resources for RNA synthesis, supporting activities in molecular biology and genetic investigations.

The primary applications of in-vitro transcription templates are in vaccine development and therapeutic production. Integral multi-tandem valves represent a category of single-unit valves that consolidate multiple control functions into a compact body. These valves find utility across various research stages including exploratory and clinical phases in treating ailments such as cancer, infectious diseases, lifestyle disorders, genetic conditions, and other medical conditions. They are utilized by pharmaceutical and biotechnology firms, contract research organizations (CROs) and contract manufacturing organizations (CMOs), academic and research institutions, and other relevant entities.

The in-vitro transcription templates market research report is one of a series of new reports from The Business Research Company that provides in-vitro transcription templates market statistics, including the in-vitro transcription templates industry global market size, regional shares, competitors with in-vitro transcription templates market share, detailed in-vitro transcription templates market segments, market trends, and opportunities, and any further data you may need to thrive in the in-vitro transcription templates industry. These in-vitro transcription templates market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in-vitro transcription templates market size has grown exponentially in recent years. It will grow from $1.01 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to rise in cases of chronic diseases, increase in investments in R&D in healthcare and pharmaceutical sectors, improvements in gene therapy technology, collaborations and partnerships and developments in gene therapy.

The in-vitro transcription templates market size is expected to see exponential growth in the next few years. It will grow to $2.9 billion in 2029 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to Increase in advancement in biotechnology, rise in focus in R&D activities, rise in usage of in-vitro transcription templates, demand for early diagnosis of diseases and increasing need for mRNA-based vaccines. Major trends in the forecast period include developments in RNA synthesis technologies, technological advancements, advancement in biotechnology, advancements in enzymatic synthesis techniques, and integration of automation and digitalization.

The rise in gene therapy's prominence is anticipated to drive growth in the in-vitro transcription templates market. Gene therapy involves modifying cellular genes to treat or prevent illnesses by rectifying defective genes. Technological advancements such as CRISPR, substantial investments, and recent treatment successes have heightened interest in this approach. In-vitro transcription templates play a crucial role in gene therapy by providing the necessary RNA molecules for mRNA-based therapies, siRNA-based therapies, and gene editing technologies, enabling the treatment of genetic disorders and diseases. For instance, as of March 2024, the Food and Drug Administration (FDA), a US-based federal agency under the Department of Health and Human Services, reported approving 36 gene therapies, with another 500 in the pipeline. They expect to approve 10-20 annually by 2025, further emphasizing the growing focus on gene therapy driving the in-vitro transcription templates market's expansion.

Key players in the in-vitro transcription templates market are actively developing self-amplifying RNA synthesis services to enhance RNA-based therapy efficiency and effectiveness, reduce production costs, and improve patient outcomes across various therapeutic applications. This technology allows RNA production capable of self-replication within host cells, leading to heightened protein expression from minimal RNA input, thereby improving RNA-based therapy efficiency and effectiveness. For example, in May 2024, GenScript Biotech Corporation, a US-based biotechnology firm, unveiled a self-amplifying RNA (saRNA) synthesis service, expanding its in-vitro transcription RNA synthesis offerings. This new service boosts the potency and efficacy of vaccines, immunotherapies, and gene therapies by enabling robust protein expression from small RNA quantities. The saRNA platform aims to decrease dosages, lower production costs, and enhance patient outcomes, supported by extensive research and development ensuring high purity and improved protein expression.

In September 2022, Lonza, a Switzerland-based pharmaceutical and biotechnology company, partnered with Torchlight to incorporate Touchlight's innovative doggybone DNA (dbDNA) technology into its mRNA development and manufacturing services. This collaboration broadens Lonza's customer offerings, providing faster, scalable, and purer alternatives to traditional plasmid DNA (pDNA) methods, strengthening Lonza's integrated mRNA manufacturing capabilities. Torchlight, a UK-based biotechnology firm, specializes in DNA production and development through an enzymatic process.

Major companies operating in the in-vitro transcription templates market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Eurofins Genomics LLC, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., Promega Corporation, Genescript Biotech Corporation, Takara Bio Inc., New England Biolabs, OriGene Technologies Inc., Cayman Chemical, Synthego Corporation, Synbio Technologies, Creative Diagnostics, VectorBuilder Inc., Bio-Synthesis Inc., TriLink BioTechnologies, Norgen Biotek Corporation, Genaxxon BioScience GmbH, Enzo Life Sciences Inc., GeneCopoeia

North America was the largest region in the in-vitro transcription templates market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro transcription templates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro transcription templates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro transcription templates market consists of revenues earned by entities by providing services such as RNA synthesis, quality control services, scale-up production, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The in-vitro transcription templates market also includes sales of DNA plasmids, linearized DNA, and synthetic oligonucleotides. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Transcription Templates Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro transcription templates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro transcription templates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro transcription templates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Vaccine; Therapeutic
• 2) By Research Stage: Exploratory; Clinical
• 3) By Disease: Cancer; Infectious Disease; Lifestyle Disease; Genetic Disease; Other Diseases
• 4) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs); Academics And Research; Other End Users
• Subsegments:
• 1) By Vaccine: MRNA Vaccines; DNA Vaccines
• 2) By Therapeutic: Gene Therapy; RNA-Based Therapeutics
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Eurofins Genomics LLC; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-Vitro Transcription Templates Market Characteristics

3. In-Vitro Transcription Templates Market Trends And Strategies

4. In-Vitro Transcription Templates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In-Vitro Transcription Templates Growth Analysis And Strategic Analysis Framework

• 5.1. Global In-Vitro Transcription Templates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global In-Vitro Transcription Templates Market Growth Rate Analysis
• 5.4. Global In-Vitro Transcription Templates Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global In-Vitro Transcription Templates Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global In-Vitro Transcription Templates Total Addressable Market (TAM)

6. In-Vitro Transcription Templates Market Segmentation

• 6.1. Global In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccine
• Therapeutic
• 6.2. Global In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exploratory
• Clinical
• 6.3. Global In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Infectious Disease
• Lifestyle Disease
• Genetic Disease
• Other Diseases
• 6.4. Global In-Vitro Transcription Templates Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
• Academics And Research
• Other End Users
• 6.5. Global In-Vitro Transcription Templates Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• MRNA Vaccines
• DNA Vaccines
• 6.6. Global In-Vitro Transcription Templates Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• RNA-Based Therapeutics

7. In-Vitro Transcription Templates Market Regional And Country Analysis

• 7.1. Global In-Vitro Transcription Templates Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global In-Vitro Transcription Templates Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-Vitro Transcription Templates Market

• 8.1. Asia-Pacific In-Vitro Transcription Templates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-Vitro Transcription Templates Market

• 9.1. China In-Vitro Transcription Templates Market Overview
• 9.2. China In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-Vitro Transcription Templates Market

• 10.1. India In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-Vitro Transcription Templates Market

• 11.1. Japan In-Vitro Transcription Templates Market Overview
• 11.2. Japan In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-Vitro Transcription Templates Market

• 12.1. Australia In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-Vitro Transcription Templates Market

• 13.1. Indonesia In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-Vitro Transcription Templates Market

• 14.1. South Korea In-Vitro Transcription Templates Market Overview
• 14.2. South Korea In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-Vitro Transcription Templates Market

• 15.1. Western Europe In-Vitro Transcription Templates Market Overview
• 15.2. Western Europe In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-Vitro Transcription Templates Market

• 16.1. UK In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-Vitro Transcription Templates Market

• 17.1. Germany In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-Vitro Transcription Templates Market

• 18.1. France In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-Vitro Transcription Templates Market

• 19.1. Italy In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-Vitro Transcription Templates Market

• 20.1. Spain In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-Vitro Transcription Templates Market

• 21.1. Eastern Europe In-Vitro Transcription Templates Market Overview
• 21.2. Eastern Europe In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-Vitro Transcription Templates Market

• 22.1. Russia In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-Vitro Transcription Templates Market

• 23.1. North America In-Vitro Transcription Templates Market Overview
• 23.2. North America In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-Vitro Transcription Templates Market

• 24.1. USA In-Vitro Transcription Templates Market Overview
• 24.2. USA In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-Vitro Transcription Templates Market

• 25.1. Canada In-Vitro Transcription Templates Market Overview
• 25.2. Canada In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-Vitro Transcription Templates Market

• 26.1. South America In-Vitro Transcription Templates Market Overview
• 26.2. South America In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-Vitro Transcription Templates Market

• 27.1. Brazil In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-Vitro Transcription Templates Market

• 28.1. Middle East In-Vitro Transcription Templates Market Overview
• 28.2. Middle East In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-Vitro Transcription Templates Market

• 29.1. Africa In-Vitro Transcription Templates Market Overview
• 29.2. Africa In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-Vitro Transcription Templates Market Competitive Landscape And Company Profiles

• 30.1. In-Vitro Transcription Templates Market Competitive Landscape
• 30.2. In-Vitro Transcription Templates Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Genomics LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. In-Vitro Transcription Templates Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Qiagen N.V.
• 31.4. Integrated DNA Technologies Inc.
• 31.5. Promega Corporation
• 31.6. Genescript Biotech Corporation
• 31.7. Takara Bio Inc.
• 31.8. New England Biolabs
• 31.9. OriGene Technologies Inc.
• 31.10. Cayman Chemical
• 31.11. Synthego Corporation
• 31.12. Synbio Technologies
• 31.13. Creative Diagnostics
• 31.14. VectorBuilder Inc.
• 31.15. Bio-Synthesis Inc.

32. Global In-Vitro Transcription Templates Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-Vitro Transcription Templates Market

34. Recent Developments In The In-Vitro Transcription Templates Market

35. In-Vitro Transcription Templates Market High Potential Countries, Segments and Strategies

• 35.1 In-Vitro Transcription Templates Market In 2029 - Countries Offering Most New Opportunities
• 35.2 In-Vitro Transcription Templates Market In 2029 - Segments Offering Most New Opportunities
• 35.3 In-Vitro Transcription Templates Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료